Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03468998 · ClinicalTrials.gov registry record · NA
The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges
A NA study of Alveolar Ridge Preservation and Alveolar Ridge Augmentation, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03468998: Completed NA study of Alveolar Ridge Preservation and Alveolar Ridge Augmentation, sponsored by University of Alabama at Birmingham.
NCT03468998 is a NA study of Alveolar Ridge Preservation and Alveolar Ridge Augmentation that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03468998, a NA study of Alveolar Ridge Preservation and Alveolar Ridge Augmentation, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effect of allograft bone particle size on the bone quantity and quality following socket grafting and lateral ridge augmentation in preparation for endosseous implant placement. Pre (baseline)- and post-grafting (3 months for sockets and 6 months for edentulous ridges) clinical as well as 2- and 3-dimensional radiographic measurements will be used to evaluate the differences between sites grafted with small vs. large particle sized bone allografts. Histological analysis will be performed at time of surgical re-entry of grafted sites to place the dental implants, and assessed for differences in new bone formation between the 2 types of grafts.
Primary Outcome
Compare histomorphometric amount of new bone formation (in %) between small and large particle bone allografts following ridge preservation and ridge augmentation procedures using core biopsies harvested at time of dental implant placement.
Conditions Studied
Interventions
- DEVICE Socket Grafting with small particle allograft
- DEVICE Socket Grafting with large particle allograft
- DEVICE Lateral ridge augmentation with small particle allograft
- DEVICE Lateral ridge augmentation with large particle allograft
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-03-08 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
What the finished NCT03468998 record still lists
NCT03468998 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Alveolar Ridge Preservation appearing as the primary indexed condition, and to 4 interventions - of which Socket Grafting with small particle allograft is the first listed.
NCT03468998 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03468998 about?
NCT03468998 is a clinical study titled "The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges". This study will evaluate the effect of allograft bone particle size on the bone quantity and quality following socket grafting and lateral ridge augmentation in preparation for endosseous implant placement. Pre (baseline)- and post-grafting (3 months for sockets and 6 months for edentulous ridges) ...
What is the current status of trial NCT03468998?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-03-08. Estimated completion is 2022-12-15.
What conditions does trial NCT03468998 study?
This clinical trial studies the following conditions: Alveolar Ridge Preservation, Alveolar Ridge Augmentation.
What interventions are being tested in trial NCT03468998?
The interventions under investigation include: Socket Grafting with small particle allograft (DEVICE), Socket Grafting with large particle allograft (DEVICE), Lateral ridge augmentation with small particle allograft (DEVICE), Lateral ridge augmentation with large particle allograft (DEVICE).
Who is sponsoring clinical trial NCT03468998?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03468998 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alveolar Ridge Preservation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03468998's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI